THE ONE BIOPHARMACEUTICAL CO., LTD.
Update：2026/09/15
Industries
Main Industry
Biotechnology
Main Product/Service
THE ONE BIOPHARMACEUTICAL CO., LTD. has launched a series of natural herbal health supplements (such as Gan Wei and Sheng Wei Compound Herbal Capsules, etc.), which have demonstrated outstanding efficacy in clinical trial data and clinical efficacy research. Through the solid medical evidence and research and development of its scientific research team, THE ONE BIOPHARMACEUTICAL CO., LTD. has developed nine new drugs and health products, with subsequent series of products also continuously under development. These products are highly favored by the public and possess extremely high market value.
(The content above was translated by AI.)
(The content above was translated by AI.)
Founded Year
2016
Unified Business No.
55954888
Status
Active
Number of Employees
0
Total Paid-in
Capital
70,000,000 (NT$)
Location of Company
Taiwan
, Hsinchu County
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
THE ONE BIOPHARMACEUTICAL CO., LTD. takes it as its mission to develop therapeutic drugs and health foods targeting cancer and chronic diseases using scientific methods, hoping to provide brand new treatment methods for cancer and chronic disease patients worldwide. "Benefiting the world and caring for life" is the founding purpose of THE ONE BIOPHARMACEUTICAL CO., LTD. THE ONE BIOPHARMACEUTICAL CO., LTD. has assembled a top product R&D advisory team composed of Academicians of Academia Sinica, well-known domestic and international academic experts, scholars, physicians, and PhD scientists, to meticulously develop targeted new drugs for liver cancer that are suitable for the physical constitution of Asians, as well as botanical new drugs developed based on natural Chinese herbal medicines. In addition to disease-oriented R&D aspects, the company also emphasizes the concept of "the superior doctor prevents disease before it occurs" in preventive medicine, conducting research directed toward clinical evidence-based medicine to exert the spirit of preventive medicine and effectively address the prevention and occurrence of diseases.
(The content above was translated by AI.)
(The content above was translated by AI.)
